Daniel R. Wagner

7.4k total citations · 1 hit paper
78 papers, 3.3k citations indexed

About

Daniel R. Wagner is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Daniel R. Wagner has authored 78 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 28 papers in Cardiology and Cardiovascular Medicine and 18 papers in Cancer Research. Recurrent topics in Daniel R. Wagner's work include Cardiac Fibrosis and Remodeling (15 papers), Adenosine and Purinergic Signaling (11 papers) and MicroRNA in disease regulation (10 papers). Daniel R. Wagner is often cited by papers focused on Cardiac Fibrosis and Remodeling (15 papers), Adenosine and Purinergic Signaling (11 papers) and MicroRNA in disease regulation (10 papers). Daniel R. Wagner collaborates with scholars based in Luxembourg, Germany and United States. Daniel R. Wagner's co-authors include Yvan Devaux, Mélanie Vausort, Francisco Azuaje, Blanche Schroen, Stéphane Heymans, Maarten F. Corsten, Isabelle Ernens, Tatiana Kuznetsova, Jan A. Staessen and Sylvia H. J. Jochems and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Bioinformatics.

In The Last Decade

Daniel R. Wagner

78 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease

2010 638 citations Maarten F. Corsten, Robert Dennert et al. Circulation Cardiovascular Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel R. Wagner Luxembourg	29	1.9k	1.6k	922	435	264	78	3.3k
Yoshitaka Iwanaga Japan	31	1.9k 1.0×	717 0.5×	2.4k 2.6×	780 1.8×	225 0.9×	176	4.7k
Edith Tzeng United States	31	1.5k 0.8×	268 0.2×	498 0.5×	573 1.3×	83 0.3×	87	3.2k
Cinzia Perrino Italy	34	1.7k 0.9×	285 0.2×	1.5k 1.7×	686 1.6×	100 0.4×	96	3.5k
Ping‐Yen Liu Taiwan	30	992 0.5×	367 0.2×	1.1k 1.1×	862 2.0×	121 0.5×	164	3.3k
Tetsuya Matoba Japan	37	1.6k 0.8×	279 0.2×	1.6k 1.7×	1.1k 2.6×	383 1.5×	122	5.1k
Rolf‐Edgar Silber Germany	29	1.3k 0.7×	338 0.2×	476 0.5×	463 1.1×	92 0.3×	80	2.9k
Brian C. Jensen United States	31	1.5k 0.8×	211 0.1×	1.4k 1.5×	339 0.8×	230 0.9×	98	3.4k
Eleonora Mezzaroma United States	33	2.3k 1.2×	201 0.1×	1.8k 1.9×	853 2.0×	95 0.4×	78	4.2k
Farhad R. Danesh United States	31	2.4k 1.3×	983 0.6×	332 0.4×	564 1.3×	58 0.2×	57	4.5k

Countries citing papers authored by Daniel R. Wagner

Since Specialization

Citations

This map shows the geographic impact of Daniel R. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Wagner more than expected).

Fields of papers citing papers by Daniel R. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Wagner. The network helps show where Daniel R. Wagner may publish in the future.

Co-authorship network of co-authors of Daniel R. Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Wagner. A scholar is included among the top collaborators of Daniel R. Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Wagner. Daniel R. Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khoruzhenko, Olena, Daniel R. Wagner, Martin Dulle, et al.. (2021). Colloidally stable, magnetoresponsive liquid crystals based on clay nanosheets. Journal of Materials Chemistry C. 9(37). 12732–12740. 5 indexed citations

Wagner, Daniel R., Thomas Götsch, Takayuki Kikuchi, et al.. (2021). Enhancing the Catalytic Activity of Palladium Nanoparticles via Sandwich-Like Confinement by Thin Titanate Nanosheets. ACS Catalysis. 11(5). 2754–2762. 21 indexed citations

Malfatti-Gasperini, Antônio A., Daniel R. Wagner, Kenneth D. Knudsen, et al.. (2020). Unmodified Clay Nanosheets at the Air–Water Interface. Langmuir. 37(1). 160–170. 7 indexed citations

Ernens, Isabelle, et al.. (2016). Use of Coronary Ultrasound Imaging to Evaluate Ventricular Function in Adult Zebrafish. Zebrafish. 13(6). 477–480. 9 indexed citations

Seronde, Marie‐France, Mélanie Vausort, Étienne Gayat, et al.. (2015). Circulating microRNAs and Outcome in Patients with Acute Heart Failure. PLoS ONE. 10(11). e0142237–e0142237. 72 indexed citations

Feldman, Arthur M., Lilin She, Dennis M. McNamara, et al.. (2015). Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials. Cardiology. 130(2). 69–81. 2 indexed citations

Zhang, Lu, Abdullah Hamad, Mélanie Vausort, et al.. (2014). Identification of Candidate Long Noncoding RNAs Associated with Left Ventricular Hypertrophy. Clinical and Translational Science. 8(2). 100–106. 13 indexed citations

Goretti, Emeline, Daniel R. Wagner, & Yvan Devaux. (2014). miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine?. Trends in Molecular Medicine. 20(12). 716–725. 76 indexed citations

Devaux, Yvan, Mélanie Vausort, Gerry P McCann, et al.. (2013). A Panel of 4 microRNAs Facilitates the Prediction of Left Ventricular Contractility after Acute Myocardial Infarction. PLoS ONE. 8(8). e70644–e70644. 105 indexed citations

10.

Stammet, Pascal, Daniel R. Wagner, Georges Gilson, & Yvan Devaux. (2013). Modeling Serum Level of S100β and Bispectral Index to Predict Outcome After Cardiac Arrest. Journal of the American College of Cardiology. 62(9). 851–858. 59 indexed citations

11.

Wagner, Daniel R., et al.. (2012). Weight and body composition change over a six-week holiday period. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 17(1). e54–e56. 12 indexed citations

12.

Serchi, Tommaso, Daniel R. Wagner, Georges Gilson, et al.. (2011). Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker. Journal of Proteomics. 75(1). 229–236. 49 indexed citations

13.

Azuaje, Francisco, Haiying Wang, Huiru Zheng, et al.. (2011). Predictive integration of gene functional similarity and co-expression defines treatment response of endothelial progenitor cells. BMC Systems Biology. 5(1). 46–46. 7 indexed citations

14.

Corsten, Maarten F., Robert Dennert, Sylvia H. J. Jochems, et al.. (2010). Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease. Circulation Cardiovascular Genetics. 3(6). 499–506. 638 indexed citations breakdown →

15.

Ciarka, Agnieszka, et al.. (2010). Right Coronary Artery Originating in the Left Ventricle. Journal of the American College of Cardiology. 56(16). 1351–1351. 1 indexed citations

16.

Sjauw, Krischan D., Thomas Konorza, Raimund Erbel, et al.. (2009). Supported High-Risk Percutaneous Coronary Intervention With the Impella 2.5 Device. Journal of the American College of Cardiology. 54(25). 2430–2434. 177 indexed citations

17.

Rouy, Didier, Frédéric Lebrun, Guy Berchem, et al.. (2008). Cell therapy for severe chronic heart failure: the Luxembourg experience.. PubMed. 18(1 Suppl). S27–31. 5 indexed citations

18.

Bueb, Jean‐Luc, et al.. (2003). Increased levels of matrix metalloproteinase-9 in patients with acute myocardial infarction: No correlation with C-reactive protein. Journal of the American College of Cardiology. 41(6). 394–394. 1 indexed citations

19.

Wagner, Daniel R., Françoise Bontemps, & Georges Berghe. (1995). The AMP — Adenosine Cycle is Active During Normoxia and Impaired in ATP Depletion in Isolated Rabbit Cardiomyocytes. Advances in experimental medicine and biology. 370. 323–326. 2 indexed citations

20.

Wagner, Daniel R., et al.. (1991). Effects of Oral Ribose on Muscle Metabolism during Bicycle Ergometer in Patients with AMP-Deaminase-Deficiency. Advances in experimental medicine and biology. 309B. 383–385. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact